SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001559053-23-000025
Filing Date
2023-08-03
Accepted
2023-08-03 16:10:09
Documents
14
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20230803.htm   iXBRL 8-K 32625
2 EX-99.1 exhibit991q22023earningsre.htm EX-99.1 112272
6 GRAPHIC q2-2023prtalogo.jpg GRAPHIC 10293
  Complete submission text file 0001559053-23-000025.txt   306501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20230803.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20230803_lab.xml EX-101.LAB 25652
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20230803_pre.xml EX-101.PRE 13538
8 EXTRACTED XBRL INSTANCE DOCUMENT prta-20230803_htm.xml XML 2933
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 231140019
SIC: 2834 Pharmaceutical Preparations